Elanco Animal Health Statistics
Share Statistics
Elanco Animal Health has 494.35M shares outstanding. The number of shares has increased by 0.33% in one year.
| Shares Outstanding | 494.35M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.03% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 486.97M |
| Failed to Deliver (FTD) Shares | 312.93K |
| FTD / Avg. Volume | 6.52% |
Short Selling Information
The latest short interest is 13.88M, so 2.81% of the outstanding shares have been sold short.
| Short Interest | 13.88M |
| Short % of Shares Out | 2.81% |
| Short % of Float | 2.85% |
| Short Ratio (days to cover) | 3.46 |
Valuation Ratios
The PE ratio is -5.96 and the forward PE ratio is 15.02.
| PE Ratio | -5.96 |
| Forward PE | 15.02 |
| PS Ratio | 1.66 |
| Forward PS | 1.3 |
| PB Ratio | 1.18 |
| P/FCF Ratio | 62.69 |
| PEG Ratio | n/a |
Enterprise Valuation
Elanco Animal Health has an Enterprise Value (EV) of 12.76B.
| EV / Earnings | -10.36 |
| EV / Sales | 2.89 |
| EV / EBITDA | -56.95 |
| EV / EBIT | 39.13 |
| EV / FCF | 109.04 |
Financial Position
The company has a current ratio of 2.75, with a Debt / Equity ratio of 0.93.
| Current Ratio | 2.75 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.93 |
| Total Debt / Capitalization | 48.13 |
| Cash Flow / Debt | 0.05 |
| Interest Coverage | 1.18 |
Financial Efficiency
Return on equity (ROE) is -0.2% and return on capital (ROIC) is 2.8%.
| Return on Equity (ROE) | -0.2% |
| Return on Assets (ROA) | -0.09% |
| Return on Capital (ROIC) | 2.8% |
| Revenue Per Employee | 474.95K |
| Profits Per Employee | -132.37K |
| Employee Count | 9.30K |
| Asset Turnover | 0.31 |
| Inventory Turnover | 1.43 |
Taxes
| Income Tax | 36.00M |
| Effective Tax Rate | -0.03 |
Stock Price Statistics
The stock price has increased by -11.92% in the last 52 weeks. The beta is 1.42, so Elanco Animal Health's price volatility has been higher than the market average.
| Beta | 1.42 |
| 52-Week Price Change | -11.92% |
| 50-Day Moving Average | 13.3 |
| 200-Day Moving Average | 14.64 |
| Relative Strength Index (RSI) | 43.31 |
| Average Volume (20 Days) | 4.80M |
Income Statement
In the last 12 months, Elanco Animal Health had revenue of $4.42B and earned -$1.23B in profits. Earnings per share was $-2.5.
| Revenue | 4.42B |
| Gross Profit | 1.94B |
| Operating Income | 326.00M |
| Net Income | -1.23B |
| EBITDA | -224.00M |
| EBIT | 326.00M |
| Earnings Per Share (EPS) | -2.5 |
Balance Sheet
The company has $352.00M in cash and $5.77B in debt, giving a net cash position of -$5.42B.
| Cash & Cash Equivalents | 352.00M |
| Total Debt | 5.77B |
| Net Cash | -5.42B |
| Retained Earnings | -2.29B |
| Total Assets | 13.28B |
| Working Capital | 2.04B |
Cash Flow
In the last 12 months, operating cash flow was $271.00M and capital expenditures -$154.00M, giving a free cash flow of $117.00M.
| Operating Cash Flow | 271.00M |
| Capital Expenditures | -154.00M |
| Free Cash Flow | 117.00M |
| FCF Per Share | 0.24 |
Margins
Gross margin is 43.88%, with operating and profit margins of 7.38% and -27.87%.
| Gross Margin | 43.88% |
| Operating Margin | 7.38% |
| Pretax Margin | -27.05% |
| Profit Margin | -27.87% |
| EBITDA Margin | -5.07% |
| EBIT Margin | 7.38% |
| FCF Margin | 2.65% |
Dividends & Yields
ELAN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -20.63% |
| FCF Yield | 1.95% |
Analyst Forecast
The average price target for ELAN is $16.5, which is 36.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $16.5 |
| Price Target Difference | 36.1% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Scores
| Altman Z-Score | 0.85 |
| Piotroski F-Score | 6 |